好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Regional Trends in Modifiable Vascular Risk Factors Among Patients Hospitalized for Stroke or TIA in the United States, 2005 to 2014
Cerebrovascular Disease and Interventional Neurology
S40 - Stroke Risk Factors and Epidemiology (4:36 PM-4:47 PM)
007

Clear socioeconomic disparities exist in stroke diagnosis and treatment thought to be related to biologic factors, access to resources, and control of modifiable vascular risk factors.  Geographic features may also play a role. 

To describe the change in modifiable vascular risk factors for patients hospitalized with acute ischemic stroke (AIS) or transient ischemic attack (TIA) over a ten-year period based on geographic region of the United States.

We analyzed temporal trends of modifiable risk factors in adult patients hospitalized for AIS/TIA in the United States from 2005 to 2014 using the National Inpatient Sample (NIS). Primary analysis evaluated the prevalence of each risk factor stratified by geographic regions.  Survey-weighted logistic regression was used to estimate the rate for each year and compared across regions before and after adjusting for age and sex.

Of 1,194,232 admissions for AIS/TIA from 2005 to 2014, 18.5% were from Northeast, South 41.7%, Midwest 22.2%, West 17.6%. Overall prevalence of hypertension was 66.1%, diabetes 32.7%, dyslipidemia 48.4%, obesity 7.8% and smoking 23.8%. South had the highest prevalence of diabetes and hypertension (p <0.001 and 0.002, respectively). Comparatively, dyslipidemia, obesity, and smoking were most prevalent in the Midwest (p<0.001). Over ten years, the prevalence of diabetes (29.2% to 36.8%), dyslipidemia (34% to 58.8%), obesity (4.7% to 11.1%), and smoking (15.8% to 32.8%) increased significantly (p<0.001), but hypertension remained persistently high (65.7% to 67.1%). Comparing time-effect by region, the temporal change from 2005 to 2014 varied significantly across regions for diabetes (p=0.02), dyslipidemia (p=0.09), hypertension (p<0.001) and smoking (p<0.001), but not obesity (p=0.44).

Despite nationwide efforts to control modifiable risk factors, admissions for AIS/TIA are associated with a significant increase in many of the modifiable vascular risk factors.  Our data demonstrates geographic variability in modifiable vascular risk factor prevalence, which can be used to drive targeted therapies regionally.
Authors/Disclosures
Melanie R. Greenway, MD (Novant)
PRESENTER
No disclosure on file
No disclosure on file
Thomas G. Brott, MD, FAAN (Mayo Clinic) Dr. Brott has nothing to disclose.
James F. Meschia, MD, FAAN (Mayo Clinic) The institution of Dr. Meschia has received research support from NINDS. The institution of Dr. Meschia has received research support from NINDS.
Kevin M. Barrett, MD, FAAN (Mayo Clinic) Dr. Barrett has nothing to disclose.
Josephine F. Huang, MD Dr. Huang has nothing to disclose.
Michelle P. Lin, CRC (Mayo Clinic Florida) Dr. Lin has nothing to disclose.